Ponatinib Hcl

Brand name: Iclusig

Rank #378 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$25.6M

Total Cost

Share:

1,209

Total Claims

$25.6M

Total Cost

82

Prescribers

$21K

Cost per Claim

0

Beneficiaries

1,221

30-Day Fills

$312K

Avg Cost/Provider

15

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$25.6M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $25.6M total

🔎 Data Overview

💰

At $21,148 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $311,808 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Ponatinib Hcl

#ProviderSpecialtyLocationClaimsCost
1Adam DuvallHematology-OncologyAnn Arbor, MI36$927K
2Laura MilliganNurse PractitionerCharleston, SC34$803K
3Jamie KoprivnikarHematology-OncologyHackensack, NJ28$661K
4Divya KouraHematology-OncologyLa Jolla, CA34$597K
5Christa JackowiczPhysician AssistantChicago, IL28$595K
6Neil PalmisianoMedical OncologyPhiladelphia, PA20$540K
7Mallory WeberPhysician AssistantChicago, IL20$529K
8Amelia LangstonMedical OncologyAtlanta, GA15$498K
9Karamjeet SandhuHematologyDuarte, CA23$497K
10Timothy KasunicHematology-OncologyToledo, OH11$473K
11Nanda GopalanHematology-OncologyEl Paso, TX22$457K
12Adam LernerHematology-OncologyBoston, MA11$428K
13Guru Subramanian Guru MurthyHematology-OncologyMilwaukee, WI20$422K
14Bertrand AnzHematology-OncologyChattanooga, TN19$407K
15Camille AbboudMedical OncologySaint Louis, MO24$398K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
375Timolol Maleate (Timolol Maleate)$25.8M1,129,537
376Amitriptyline Hcl (Amitriptyline Hcl)$25.8M1,295,043
377Tezepelumab-Ekko (Tezspire)$25.6M5,900
378Ponatinib Hcl (Iclusig)$25.6M1,209
379Citalopram Hydrobromide (Citalopram Hbr)$25.3M2,778,255
380Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass)$25.3M2,207,997
381Infliximab (Remicade)$25.3M3,457

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology